Gastric mechanoreceptor

Gastric mechanoreceptors are **sensory nerve endings** located within the wall of the stomach that detect mechanical changes such as stretch (distension) and tension. These receptors play an essential role in regulating gastrointestinal functions by sensing when the stomach is filled during food intake. There are two main types described: - **Tension receptors** respond to increases in circular tension within the stomach wall. - **Elongation/Stretch receptors** respond to elongation/stretching forces parallel to smooth muscle fibers. Activation of these receptors triggers neural signals—primarily via vagal afferents—to the brainstem, contributing to sensations such as fullness and initiating reflexes that regulate gastric accommodation and motility. This process underlies meal-induced satiation and helps determine how much food can be comfortably ingested at one time[1][5][6]. Mechanotransduction at these sites involves various ion channels—such as Piezo2—and possibly other molecules expressed on sensory neurons innervating the stomach wall[4]. The term “gastric mechanoreceptor” does not refer to a unique protein or gene product but rather describes a physiological function carried out by specialized nerve endings equipped with different types of mechanically sensitive channels. Because “gastric mechanoreceptor” is not a single defined molecule but rather refers collectively to several types of sensory structures performing similar roles, it is **not considered an individual therapeutic target** like GPCRs or enzymes. Instead, it represents an anatomical/functional concept encompassing multiple possible molecular entities involved in mechanical signal detection within the stomach. As such, there are no drugs that directly target "gastric mechanoreceptors" as a defined molecular entity; some drugs may modulate their function indirectly by affecting gastric tone or neurotransmitter release. Similarly, no specific biomarkers exist for patient selection or efficacy monitoring related to "gastric mechanoreceptors" as a molecular target, and there are no direct safety concerns associated with targeting this entity because it is not a single druggable molecule. References supporting this information include studies describing their physiological roles,[1][3][4][5] classification,[6] involvement in disease states,[1] mechanisms underlying activation,[4] and lack of direct pharmacological targeting.

Other names

Gastric stretch receptorGastric tension receptorGastric mucosal mechanoreceptorVisceral mechanoreceptor (stomach)

Drugs do not act directly on "gastric mechanoreceptors" but may influence their activity through modulation of gastric tone, neurotransmitter systems such as acetylcholine or serotonin, or peptide hormones like cholecystokinin and GLP‑1.[3][5]